CLAY STALCUP: Open Payments
NPI 1750389979 · SEYMOUR, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 74 payments from 16 companies in 2025. Trend: 2023 $838 · 2024 $1,200 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $210 |
| Novo Nordisk Inc | 11 | $202 |
| Axsome Therapeutics, Inc. | 10 | $193 |
| AstraZeneca Pharmaceuticals LP | 8 | $148 |
| ABBVIE INC. | 5 | $96 |
| PFIZER INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Esperion Therapeutics, Inc. | 3 | $47 |
| Eisai Inc. | 2 | $43 |
Products named: CAPLYTA, Auvelity, Ozempic, AIRSUPRA, PREVNAR 20, VRAYLAR, TRELEGY ELLIPTA, Wegovy.
Industry payments across TN — which companies pay providers there.
